Second Amendment to the Exclusive Patent License and Research Collaboration AgreementCollaboration Agreement • November 10th, 2021 • Sutro Biopharma, Inc. • Biological products, (no disgnostic substances)
Contract Type FiledNovember 10th, 2021 Company IndustryThis Second Amendment to the Exclusive Patent License and Research Collaboration Agreement between the Parties, effective as of July 23, 2018, and as subsequently amended by Amendment #1, effective as of August 26, 2020 (the “Agreement”), is entered into and effective as of the date of last signature below ("Amendment #2") by and between SUTRO BIOPHARMA, INC., a corporation organized and existing under the laws of Delaware (“Sutro”), and MERCK SHARP & DOHME CORP., a corporation organized and existing under the laws of the State of New Jersey (“Merck”).